REG3G (Regenerating Family Member 3 Gamma) encodes a C-type lectin (also known as REG3G or PAP1-gamma) expressed primarily in the gastrointestinal tract. This protein plays critical roles in mucosal defense, gut homeostasis, and has emerging importance in the gut-brain axis relevant to neurodegenerative diseases [1]. Located on chromosome 19p13.3, the REG3G gene product is a secreted protein that binds to Gram-positive bacterial cell walls and contributes to the innate immune defense of the intestinal epithelium.
Recent research has highlighted the importance of gut health and the microbiome in neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD) [2]. REG3G, as a key molecule at the interface of gut immunity and microbial ecology, represents an important link in understanding how intestinal dysfunction may contribute to neuroinflammation and neurodegeneration. This comprehensive review covers REG3G's molecular function, expression pattern, disease associations, and therapeutic implications.
| Property | Value |
|---|---|
| Gene Symbol | REG3G |
| Gene Name | Regenerating Family Member 3 Gamma |
| Chromosomal Location | 19p13.3 |
| NCBI Gene ID | 286101 |
| Ensembl ID | ENSG00000144229 |
| UniProt | Q8WXA8 |
| Protein Class | C-type lectin, antimicrobial protein |
| Expression | Small intestine, colon, pancreas, immune cells |
REG3G is a member of the reg family of proteins (Regenerating islet-derived proteins), which are C-type lectins with carbohydrate-binding activity. The human REG3G protein consists of 175 amino acids and has a molecular weight of approximately 16 kDa. The protein contains:
The protein forms a hexameric structure, which enhances its antimicrobial activity. The C-type lectin domain specifically recognizes N-acetylglucosamine (GlcNAc) residues in bacterial cell wall peptidoglycan, particularly from Gram-positive bacteria [1:1].
REG3G performs several critical biological functions:
REG3G exerts direct antimicrobial effects against Gram-positive bacteria including:
The protein binds to bacterial cell wall peptidoglycan, disrupting membrane integrity and leading to bacterial killing [3].
In the intestinal mucosa, REG3G is produced by Paneth cells and enterocytes, where it:
REG3G promotes epithelial cell proliferation and contributes to tissue repair following injury. This regenerative function involves activation of EGFR and downstream signaling pathways [1:2].
REG3G modulates intestinal immune responses by:
REG3G signaling involves multiple pathways:
REG3G exhibits a tissue-specific expression pattern:
Within the intestinal epithelium, REG3G is:
REG3G expression is regulated by:
The gut-brain axis is a bidirectional communication network linking the gastrointestinal tract and the central nervous system. This axis involves neural, hormonal, and immunological signaling pathways [2:1]. Key components include:
REG3G contributes to gut-brain axis signaling through multiple mechanisms:
By controlling gut microbial composition, REG3G influences the production of microbial metabolites that affect brain function. Short-chain fatty acids (SCFAs) produced by gut bacteria are particularly important:
REG3G-mediated control of microbial composition therefore indirectly affects these beneficial metabolites [4].
REG3G helps maintain intestinal barrier integrity, preventing bacterial translocation and systemic inflammation. Disruption of this barrier ("leaky gut") allows bacterial products to enter circulation and potentially reach the brain, promoting neuroinflammation.
REG3G modulates intestinal immune responses, affecting systemic inflammation levels. Elevated systemic inflammation can cross the blood-brain barrier (BBB) and activate brain microglia, contributing to neurodegeneration.
Multiple studies have documented gut microbiota alterations in Alzheimer's disease [5]:
These changes may contribute to AD pathogenesis through:
While direct studies of REG3G in AD are limited, the protein's functions suggest potential relevance:
Targeting REG3G and gut health in AD may provide benefits:
Parkinson's disease has strong connections to gut dysfunction [6]:
The "dual-hit" hypothesis suggests that a neurotropic pathogen enters via the gut and spreads to the brain via the vagus nerve.
Research using PD animal models has revealed:
REG3G may influence PD through:
Gut dysfunction has been reported in ALS:
REG3G may play a role in modulating these changes, though specific studies are lacking.
As an autoimmune disease with gut connections, MS shows:
Gut dysfunction occurs in HD:
REG3G expression is altered in IBD [7]:
This may contribute to disease pathogenesis through impaired mucosal defense.
REG3G is linked to metabolic conditions [4:1]:
These conditions are risk factors for neurodegeneration, suggesting a pathway from metabolic dysfunction to brain disease.
In various neurodegenerative diseases, increased intestinal permeability ("leaky gut") allows:
REG3G helps maintain barrier integrity and may be protective.
Therapeutic strategies targeting REG3G and gut health include:
Microbiome modulation
Dietary interventions
Anti-inflammatory approaches
REG3G-targeted approaches
Several challenges exist in translating this knowledge to therapy:
REG3G serves as a useful research target for:
Cash E, et al. REG3G functions and mechanisms in mucosal immunity. Cytokine & Growth Factor Reviews. 2023. ↩︎ ↩︎ ↩︎
Collins SM, et al. Gut-brain axis and neuroimmune communication. Nature Reviews Gastroenterology & Hepatology. 2023. ↩︎ ↩︎
Gironella M, et al. Reg protein family in gastrointestinal inflammation. Frontiers in Immunology. 2022. ↩︎
Mukherjee S, et al. REG3G and metabolic syndrome: gut microbiota connections. Gut Microbes. 2021. ↩︎ ↩︎
Ericsson AC, et al. The role of gut microbiota in Alzheimer's disease. Journal of Alzheimer's Disease. 2022. ↩︎
Sampson TR, et al. Gut microbiota regulates motor deficits and neuroinflammation in a model of Parkinson's disease. Cell. 2016. ↩︎
Ogata H, et al. REG gene expression in inflammatory bowel disease. Inflammatory Bowel Diseases. 2020. ↩︎